Jason Neilsen, MD
Family Medicine · Spokane, WANPI 1164802062
Payments from drug & device makers
Across 39 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$254
- Boston Scientific$83
- Novo Nordisk$50
- Phathom Pharmaceuticals, Inc.$49
- Pfizer$39
- Cranial Technologies, Inc$34
- plus $178 from 9 others
What the payments were for
- Food & beverage$687100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $254 |
| Boston Scientific | 5 | $83 |
| Novo Nordisk | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Pfizer | 2 | $39 |
| Cranial Technologies, Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Exact Sciences | 2 | $28 |
| Eisai Inc. | 2 | $24 |
| Boehringer Ingelheim | 1 | $19 |
| Merck | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $15 |
| Amicus Therapeutics, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| GSK | 1 | $13 |
How this compares
$687 in reported general payments places this provider in the 80th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bydureon BciseExenatide Microspheres | 12 | $9,959 |
| Comfort Ez Pen NeedlePen Needle, Diabetic | 12 | $1,046 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $804 |
| Levothyroxine Sodium | 90 | $788 |
| Atorvastatin Calcium | 75 | $779 |
| Metoprolol Succinate | 29 | $699 |
| Metformin Hcl ErMetformin Hcl | 32 | $481 |
| Pregabalin | 30 | $427 |
| Gabapentin | 29 | $418 |
| Diclofenac Sodium | 12 | $381 |
| Alprazolam | 14 | $353 |
| Omeprazole | 30 | $319 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $312 |
| Amlodipine Besylate | 38 | $299 |
| Fluticasone Propionate | 14 | $285 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Spokane
- Angela EakinSpokane$3M
- Gary GleasonSpokane$178K
- Stephenie MatosichSpokane$29K
- Duncan LahtinenSpokane$25K
- Gretchen LasalleSpokane$19K
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.